Skip to main content

Find Clinical Trials

Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,110 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Not Yet Recruiting

A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic Melanoma

NCT07651618

Conditions: Melanoma, Melanoma (Skin Cancer), Melanoma Metastatic, +11 more
Locations: Royal Perth Hospital Perth, Western Australia, Australia

View Trial Details

Not Yet Recruiting

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

NCT07645742

Conditions: Adenocarcinoma, Cancer (Advanced Stage), Carcinoma, +29 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy

NCT07628894

Conditions: Advanced Cutaneous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +13 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

NCT07527325

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States

View Trial Details

Not Yet Recruiting

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

NCT07621614

Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure

NCT07619898

Conditions: Colitis, Colonic Diseases, Digestive System Diseases, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma

NCT07615881

Conditions: Melanoma, Melanoma (Skin Cancer), Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

NCT07340619

Conditions: Melanoma, Metastatic (Stage IV) Melanoma, Neoplasm Metastasis, +14 more
Locations: Institut Bergonie Bordeaux, France

Centre Leon Berard Lyon, France

Institut Paoli Calmettes Marseille, France

Centre Antoine Lacassagne Nice, France

View Trial Details

Not Yet Recruiting

Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma

NCT07581509

Conditions: Adult Patients With Stage IIB, IIC, and Stage III Melanoma Following Complete Resection (Adjuvant Settings), Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

NCT07576725

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
Locations: Uganda Cancer Institute Kampala, Uganda

View Trial Details